Drug Profile
Research programme: viral therapeutics - Novavax
Alternative Names: BCT 100 0.1Latest Information Update: 28 Nov 2006
Price :
$50
*
At a glance
- Originator Novavax
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Viral infections
Most Recent Events
- 05 Mar 2001 No-Development-Reported for Viral infections in USA (Unknown route)
- 23 Dec 1998 Preclinical development for Viral infections in USA (Unknown route)
- 14 Sep 1998 No-Development-Reported for Viral infections in USA (Unknown route)